A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

Clinical trial NCT06929156 · COMPLETED

Trial details

NCT number: NCT06929156
Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)Overweight or Obese

Start date: 2025-05-06
Primary completion: 2025-12-25
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.